The Blue Distinction(R) Center for Specialty Care designation is awarded by the BC/BS companies to medical facilities that have demonstrated experience in delivering quality healthcare. The Blood and Marrow Stem Cell Transplantation Program is one of 70 Blue Distinction(R) Centers for Transplants nationwide, but the only one in New Jersey. The designation is based on evidence-based selection criteria established with leading medical specialists and societies, including the Center for International Blood and Marrow Transplant Research and the Foundation for the Accreditation of Cellular Therapy. In achieving the Blue Distinction(R) Center designation, the program was evaluated on volume of cases, survival, a stable team of transplantation experts and subspecialists, the facility, data management, patient management plans, post-operative phase, patient education, policies and procedures, quality management, and patient satisfaction review process.
The John Theurer Cancer Center's Blood and Marrow Stem Cell Transplantation Program is the only one in New Jersey that is approved by the National Marrow Donor Program to perform all types of transplants: autologous (using the patient's own stem cells), allogeneic (using a donor's stem cells), and umbilical cord (using stem cells collected from umbilical cords). Many of the advances in stem cell transplantation techniques used today were developed here. There are currently more than 50 clinical trials under way at the program.
The John Theurer Cancer Center provides extraordinary cancer care by
offering multidisciplinary care, personalized treatment, innovative
research, superior outcomes, and patient satisfaction within 14
|SOURCE John Theurer Cancer Center|
Copyright©2008 PR Newswire.
All rights reserved